Initiation - Spark Newswire

1 minute read

B of A Securities Initiates Coverage On Marriott Vacations with Neutral Rating, Announces Price Target of $180

Today, 3:57 PM

B of A Securities analyst Shaun Kelley initiates coverage on Marriott Vacations (NYSE:VAC) with a Neutral rating and announces Price Target of $180.

VAC

1 minute read

BMO Capital Initiates Coverage On Rexford Industrial Realty with Outperform Rating, Announces Price Target of $77

By Benzinga Newsdesk

Today, 3:57 PM

BMO Capital analyst John Kim initiates coverage on Rexford Industrial Realty (NYSE:REXR) with a Outperform rating and announces Price Target of $77.

REXR

1 minute read

BMO Capital Initiates Coverage On Stag Industrial with Outperform Rating, Announces Price Target of $41

By Benzinga Newsdesk

Today, 3:57 PM

BMO Capital analyst Eric Borden initiates coverage on Stag Industrial (NYSE:STAG) with a Outperform rating and announces Price Target of $41.

STAG

1 minute read

Why This Herbalife Nutrition Analyst Cannot Digest The Business Model

By Priya Nigam

Today, 3:57 PM

Herbalife Nutrition Ltd (NYSE: HLF) was gearing up to report its quarterly earnings on Feb. 14. The company’s greatest challenge was its multi-level marketer (MLM) business model, according to BofA Securities.

HLF

1 minute read

Janney Montgomery Scott Initiates Coverage On Enphase Energy with Neutral Rating, Announces Price Target of $238

By Benzinga Newsdesk

Today, 3:57 PM

Janney Montgomery Scott analyst Sean Milligan initiates coverage on Enphase Energy (NASDAQ:ENPH) with a Neutral rating and announces Price Target of $238.

ENPH

1 minute read

Oppenheimer Initiates Coverage On Day One Biopharmaceutical with Perform Rating

By Benzinga Newsdesk

Today, 3:57 PM

Oppenheimer analyst Matthew Biegler initiates coverage on Day One Biopharmaceutical (NASDAQ:DAWN) with a Perform rating.

DAWN

1 minute read

Oppenheimer Initiates Coverage On Relay Therapeutics with Outperform Rating, Announces Price Target of $33

By Benzinga Newsdesk

Today, 3:57 PM

Oppenheimer analyst Matthew Biegler initiates coverage on Relay Therapeutics (NASDAQ:RLAY) with a Outperform rating and announces Price Target of $33.

RLAY

1 minute read

Analyst Initiates Coverage On Accolade, Says ‘Differentiated In Growing Market’

By Vandana Singh

Today, 3:57 PM

Raymond James initiated coverage on Accolade Inc (NASDAQ:ACCD) with an Outperform rating and a $15 price target. Employers have increasingly added disconnected…

ACCD

2 minute read

Guggenheim Initiates Darden Restaurants With A Buy: ‘Good Times, Great Stock, Olive Garden’

By AJ Fabino

Today, 3:57 PM

Analysts at Guggenheim Partners had not rescinded their initial outlook that the restaurant industry would struggle to structurally grow margins as long as the unemployment rate stayed below 4%. But the firm said Thursday it was betting on one group to outperform.

DRI